Informations sur le produit
RO 8994 is a MDM2 inhibitor that has been shown to inhibit the proliferation of myeloproliferative disorders. It has been found to be an effective treatment for primary myelofibrosis, which is characterized by excessive production of blood cells in the bone marrow. The drug blocks the binding of interferons to their receptors, which leads to reduced levels of interferon-induced proteins and decreased expression of PD-L1 on T cells. This drug also inhibits the production and release of cytokines from T cells, which may lead to cancer and other autoimmune diseases. RO 8994 is a non-nucleoside with a novel mechanism of action that binds to the pd-1 receptor and prevents its activation.
Propriétés chimiques
Question d’ordre technique sur : 3D-JCC68494 RO 8994
Si vous souhaitez demander un devis ou passer commande, veuillez plutôt ajouter les produits souhaités à votre panier, puis demander un devis ou passer commande à partir de votre panier. C'est une méthode plus rapide, plus économique, et vous pourrez bénéficier des remises disponibles ainsi que d'autres avantages
